Jane Street Group, LLC Akero Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$21.45 - $29.34 $4.1 Million - $5.61 Million	191,300 New	191,300 $5.49 Million
Q1 2022 May 17, 2022	SELL	$12.97 - $22.26 $160,828 - $276,024	-12,400 Reduced 35.03%	23,000 $326,000
Q4 2021 Feb 15, 2022	SELL	$19.87 - $26.24 $11,922 - $15,743	-600 Reduced 1.67%	35,400 $749,000
Q3 2021 Nov 16, 2021	BUY	$18.65 - $25.46 $512,874 - $700,150	27,500 Added 323.53%	36,000 $805,000
Q1 2021 May 18, 2021	BUY	$24.04 - $34.19 $204,340 - $290,615	8,500 New	8,500 $247,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.42B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.